<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04028414</url>
  </required_header>
  <id_info>
    <org_study_id>W81XWH-18-1-0810</org_study_id>
    <nct_id>NCT04028414</nct_id>
  </id_info>
  <brief_title>Effects of Early Weight Bearing on Rehabilitation Outcomes in Patients With Traumatic Ankle and Tibial Plateau Fractures</brief_title>
  <official_title>Effects of Early Weight Bearing on Rehabilitation Outcomes in Patients With Traumatic Ankle and Tibial Plateau Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Major Extremity Trauma Research Consortium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Major Extremity Trauma Research Consortium</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this study is to compare outcomes following early versus delayed&#xD;
      weight bearing for adult patients operatively treated for an ankle fracture without&#xD;
      syndesmotic fixation. Additionally, early weight bearing will be tested in patients with&#xD;
      unicondylar plateau fractures that do not involve joint impaction in the context of a pilot&#xD;
      study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this multi-center, randomized controlled trial (RCT) is to compare outcomes&#xD;
      following early versus delayed weight bearing among individuals with a traumatic ankle&#xD;
      fracture. This study will enroll patients ages 18 or older surgically treated for an ankle&#xD;
      fracture or fracture dislocation (without syndesmosis) at participating civilian trauma&#xD;
      centers and military treatment facilities. Eligible patients will be identified during&#xD;
      hospitalization for definitive treatment and enrolled prior to discharge or at the first post&#xD;
      op clinic visit. Patients that consent to participate will complete a baseline assessment at&#xD;
      the first post op clinic visit and will be randomized to early versus delayed weight bearing.&#xD;
      Both treatment groups will receive standardized exercises that can be done at home or with a&#xD;
      therapist. Outcomes will be evaluated at 6 weeks, 3, 6 and 12 months following definitive&#xD;
      fracture fixation. All 6 week, 3 and 6 month evaluations will take place in the surgeon's&#xD;
      outpatient clinic and involve clinical and radiographic assessments of healing as well as&#xD;
      functional outcome surveys. The 12 month evaluation will be conducted by phone except for&#xD;
      individuals who were judged not to be healed (clinically or radiographically) at 6 months;&#xD;
      these participants will be asked to return for their 12 month evaluation (to assess healing).&#xD;
      Simultaneously, a pilot RCT will be conducted in patients 18 or older surgically treated with&#xD;
      a unicondylar plateau fracture without joint impaction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Study Related Complications Experienced</measure>
    <time_frame>12 months</time_frame>
    <description>Re-admissions for a limb related issue and all re-operations on the study limb will be prospectively tracked by the Research Coordinators by routinely scanning hospital admission and orthopaedic surgery logs to identify all admissions and same day surgeries of patients actively enrolled in the study. Complications include loss of reduction and hardware failure, infection, non-union, malunion and fusion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Return to Usual Major Activity and Work Productivity</measure>
    <time_frame>12 months</time_frame>
    <description>Participants will be asked what they were doing most of the time during the previous two weeks (working/active duty, laid off/looking for work, going to school, taking care of a home, etc.). If participants are working, the Work Productivity and Activity Impairment (WPAI) questionnaire will be administered.The WPAI measures work time missed and work and activity impairment because of a specified health problem during the past 7 days (http://www.reillyassociates.net/WPAI_SHP.html).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-Reported Measures of Function</measure>
    <time_frame>12 months</time_frame>
    <description>Self-Reported Measures of Function will be assessed at 6 weeks and 3, 6 and 12 months post-injury using the Patient Reported Outcomes Measurement Information System (PROMIS) Computer Adaptive Test (CAT) item banks, a product of the NIH Roadmap for Medical Research</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>12 months</time_frame>
    <description>Pain will be measured using the Brief Pain Inventory (BPI) pain intensity domain at 3, 6 and 12 months. 27 The BPI pain intensity domain is compatible with the IMMPACT guidelines for assessing pain in clinical trials and the FDA Guidance for Industry on the use of Patient-Reported Outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Interference</measure>
    <time_frame>12 months</time_frame>
    <description>Pain will also be measured using the PROMIS Pain interference subscale. In addition, at each follow-up, the treating surgeon will also record the type and frequency of pain medications (grouped as acetaminophen, opioids, GABA analogues, NSAIDs and other).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Joint Range of Motion (ROM)</measure>
    <time_frame>6 months</time_frame>
    <description>Joint range of motion (ROM) will be assessed using a plastic goniometer, an inexpensive device with two plastic arms that are aligned with relevant body segments to quickly provide joint angle information.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Rehabilitation</condition>
  <arm_group>
    <arm_group_label>Early Weight Bearing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with ankle fractures will be instructed to weight bear as tolerated (WBAT) while in a boot with a heel to toe normal gait and wean from walker or crutches to a cane or no support device. At the 6 week post op visit, patients with ankle fractures will be instructed to wean from the boot and continue full weight bearing as tolerated until full weight bearing is achieved. Patients with plateau fractures will be instructed to begin WBAT until full weight bearing is achieved.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed Weight Bearing</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients with ankle fractures will be instructed to touch-down (toe touch or foot flat) weight bear (approximately 10% of body weight) while in the boot for. Patients will be instructed to keep foot off of floor or set ball of foot or heal on ground for balance using walker or crutches at all times. After the 6 week post op visit, patients may begin weight bearing as tolerated. Patients with tibial plateau fractures will be instructed to touch down (toe touch or foot flat) weight bear (approximately 10% of body weight) for at least 6 weeks. After the 6 week post op visit, patients may begin weight bearing as tolerated until full weight bearing is achieved.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Early Weight Bearing</intervention_name>
    <description>Patients will be instruction to weight bear as tolerated while in a boot.</description>
    <arm_group_label>Early Weight Bearing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults ages 18 or older&#xD;
&#xD;
          2. Surgically treated open or closed fractures of the ankle (OTA Codes 44A,B,C) meeting&#xD;
             one of the following criteria:&#xD;
&#xD;
               1. bimalleolar fracture requiring fixation of any two malleoli (i.e. lateral/medial,&#xD;
                  medial/posterior, lateral/posterior)&#xD;
&#xD;
               2. bimalleolar equivalent SER4 fractures (lateral malleolus fracture requiring&#xD;
                  fixation and no medial or posterior malleolus fixation)&#xD;
&#xD;
               3. trimalleolar fracture with fixation of at least two malleoli (i.e.&#xD;
                  lateral/medial, medial/posterior, lateral/posterior)&#xD;
&#xD;
          3. Operative treatment of an isolated lower extremity unicondylar tibial plateau fracture&#xD;
             (AO/OTA 41B1, Schatzker Type 1or 4) without joint impaction.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Gustilo Type III injuries or soft tissue injury of either lower extremity that would&#xD;
             contra-indicate immediate or delayed WB&#xD;
&#xD;
          2. Syndesmotic injuries/fixation&#xD;
&#xD;
          3. Osteoporosis as defined by treatment with a bisphosphonate and/or other osteoporosis&#xD;
             medications, including Prolia and Forteo; or a prior fragility fracture (e.g., spine&#xD;
             compression, proximal humerus, distal radius, femoral neck/intertrochanteric fracture)&#xD;
&#xD;
          4. Neuropathy, defined as diagnosis of peripheral neuropathy in medical record,&#xD;
             neuropathic foot ulcer, or diminished or absent plantar sensation to light touch.&#xD;
&#xD;
          5. Pathologic fracture related to neoplasm&#xD;
&#xD;
          6. Fractures and dislocations to the ipsilateral or contralateral lower limb that prevent&#xD;
             weight bearing as tolerated after fist post-op visit&#xD;
&#xD;
          7. Other contra-indication to immediate or delayed weight bearing (e.g., ipsilateral&#xD;
             fracture effecting weight bearing status such as a calcaneus fracture); fractures of&#xD;
             the ipsilateral lower extremity that would not affect WB status may be included (e.g.,&#xD;
             proximal femur, femoral shaft or tibia shaft fractures)&#xD;
&#xD;
          8. Any upper limb injury that would limit upper extremity weight bearing (e.g., surgical&#xD;
             neck fracture of proximal humerus)&#xD;
&#xD;
          9. Injuries to other body systems that would affect the ability to comply with either WB&#xD;
             protocol (e.g., spinal cord injury; severe TBI; major abdominal or chest injury)&#xD;
&#xD;
         10. Patient has third degree burns on &gt;10% total surface area affecting the study limb&#xD;
&#xD;
         11. Tibial plateau fractures that are required to wear a locking brace or fractures that&#xD;
             require fixed immobilization beyond four weeks (e.g., cast)&#xD;
&#xD;
         12. Non-ambulatory pre-injury&#xD;
&#xD;
         13. Pre-injury limitation to ROM of ipsilateral hip, knee or ankle&#xD;
&#xD;
         14. Morbidly obese (BMI â‰¥40)&#xD;
&#xD;
         15. Documented psychiatric disorder requiring admission in perioperative period&#xD;
&#xD;
         16. Severe problems with maintaining follow-up (e.g., patients who are prisoners or&#xD;
             homeless at the time of injury or who are intellectually challenged without adequate&#xD;
             family support)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa Reider, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Major Extremity Trauma Research Consortium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ELIZABETH WYSOCKI, MS</last_name>
    <phone>4109550396</phone>
    <email>ewysock2@jhu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Candice Dubose, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Theodore Miclau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Roman Natoli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland R Adams Cowley Shock Trauma Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Robert O'Toole, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Benjamin Potter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hennepin County Medical Center / Regions Hospita</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andrew Schmidt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Leah Gitajn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Madhav Karunakar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Womack Army Medical Center at Ft. Bragg</name>
      <address>
        <city>Fort Bragg</city>
        <state>North Carolina</state>
        <zip>28100</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Kenneth Nelson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jason Halvorson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David Teague, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>J Spence Reid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gele Maloney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>William T. Obremskey, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center - Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Joshua Gary, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Antonio Military Medical Center (SAMMC)</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jason Alderete, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David Weiss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Robert Hymes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington/Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mike Githens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Paul Whiting, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 17, 2019</study_first_submitted>
  <study_first_submitted_qc>July 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2019</study_first_posted>
  <last_update_submitted>October 6, 2021</last_update_submitted>
  <last_update_submitted_qc>October 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data sharing beyond manuscripts and scientific presentations will be processed through the METRC website in the short term. Currently, a standard form will be available for researchers outside METRC to request access to final data generated from METRC studies. These requests will be transmitted to the METRC Coordinating Center for initial review to make sure the relevant materials are provided in support of the request. METRC is committed to making data as widely available as possible while safeguarding the privacy of study participants and protecting the intellectual property of the Consortium.&#xD;
Data will only be made available after it is completely stripped of identifiable information such as dates, geographic locators, and any other event information which is sufficiently rare as to make it possible to deduce the identity of an individual participant. When necessary for complete de-identification, data may be grouped.</ipd_description>
    <ipd_time_frame>Once study activities are complete.</ipd_time_frame>
    <ipd_access_criteria>See plan description.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

